Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells: Redundant roles for PiT-1 and PiT-2

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 11, 2013, Pages 2625-2632

  Crouthamel, Matthew H ^a   Lau, Wei Ling ^b   Leaf, Elizabeth M ^a   Chavkin, Nicholas W ^a   Wallingford, Mary C ^a   Peterson, Danielle F ^a   Li, Xianwu ^a   Liu, Yonggang ^b   Chin, Michael T ^b   Levi, Moshe ^c   Giachelli, Cecilia M ^a  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

phosphate; PiT 1; PiT 2; vascular calcification; vascular smooth muscle cell

Indexed keywords

MESSENGER RNA; PHOSPHATE; SODIUM PHOSPHATE COTRANSPORTER; TRANSCRIPTION FACTOR PIT 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA MEDIA; ARTERY CALCIFICATION; ARTICLE; CELL CULTURE; CELL ISOLATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; GENE EXPRESSION; GENOTYPE; HISTOPATHOLOGY; IN VITRO STUDY; MOUSE; NONHUMAN; PHOSPHATE INTAKE; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; UPREGULATION; UREMIA; VASCULAR RING; VASCULAR SMOOTH MUSCLE;

PHOSPHATE; PIT-1; PIT-2; VASCULAR CALCIFICATION; VASCULAR SMOOTH MUSCLE CELL;

ANIMALS; AORTA; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; PHOSPHATES; RENAL INSUFFICIENCY, CHRONIC; RNA, MESSENGER; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; UREMIA; VASCULAR CALCIFICATION;

EID: 84887075888     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.302249     Document Type: Article

References (45)

1. U.S. Renal Data System (usrds) 2011 Annual Data Report. Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. http://www.usrds.org/adr.htm. Accessed March 1, 2013.
2. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial cal-cifcations, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension. 2001;38:938-942.
3. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, et al. Coronary-artery calcifcation in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342:1478-1483.
4. Schlieper G, Aretz A, Verberckmoes SC, Krüger T, Behets GJ, Ghadimi R, et al. Ultrastructural analysis of vascular calcifcations in uremia. J Am Soc Nephrol. 2010;21:689-696.
5. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, et al. Dialysis accelerates medial vascular calcifcation in part by triggering smooth muscle cell apoptosis. Circulation. 2008;118:1748-1757.
6. Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil R III. Arterial calcifcation and pathology in uremic patients undergoing dialysis. Am J Med. 1979;66:790-796.
7. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med. 2007;167:879-885.
8. Kestenbaum BR, Adeney KL, de Boer IH, Ix JH, Shlipak MG, Siscovick DS. Incidence and progression of coronary calcifcation in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis. Kidney Int. 2009;76:991-998.
9. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, et al. Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation. 2009;120:1784-1792.
10. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, et al. Phosphate regulation of vascular smooth muscle cell calcifcation. Circ Res. 2000;87:E10-E17.
11. Giachelli CM, Jono S, Shioi A, Nishizawa Y, Mori K, Morii H. Vascular calcifcation and inorganic phosphate. Am J Kidney Dis. 2001;38(4 Suppl 1):S34-S37.
12. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC. Phosphate-induced vascular calcifcation: role of pyrophosphate and osteopontin. J Am Soc Nephrol. 2004;15:1392-1401.
13. Lau WL, Pai A, Moe SM, Giachelli CM. Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis. 2011;18:105-112.
14. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial cal-cifcation in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109:697-711.
15. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, et al. Smooth muscle cell phenotypic transition associated with calcifca-tion: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res. 2001;89:1147-1154.
16. Reimer RJ, Edwards RH. Organic anion transport is the primary function of the SLC17/type I phosphate transporter family. Pfugers Arch. 2004;447:629-635.
17. Marks J, Debnam ES, Unwin RJ. Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol. 2010;299:F285-F296.
18. Werner A, Dehmelt L, Nalbant P. Na+-dependent phosphate cotransport-ers: the NaPi protein families. J Exp Biol. 1998;201(Pt 23):3135-3142.
19. Kavanaugh MP, Miller DG, Zhang W, Law W, Kozak SL, Kabat D, et al. Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci USA. 1994;91:7071-7075.
20. Villa-Bellosta R, Bogaert YE, Levi M, Sorribas V. Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcifcation. Arterioscler Thromb Vasc Biol. 2007;27:1030-1036.
21. Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcifcation. Circ Res. 2006;98:905-912.
22. Olah Z, Lehel C, Anderson WB, Eiden MV, Wilson CA. The cellular receptor for gibbon ape leukemia virus is a novel high affnity sodium-dependent phosphate transporter. J Biol Chem. 1994;269:25426-25431.
23. Bøttger P, Hede SE, Grunnet M, Høyer B, Klaerke DA, Pedersen L. Characterization of transport mechanisms and determinants critical for Na+-dependent Pi symport of the PiT family paralogs human PiT1 and PiT2. Am J Physiol Cell Physiol. 2006;291:C1377-C1387.
24. Beck L, Leroy C, Beck-Cormier S, Forand A, Salaün C, Paris N, et al. The phosphate transporter PiT1 (Slc20a1) revealed as a new essential gene for mouse liver development. PLoS ONE. 2010;5:e9148.
25. El-Abbadi MM, Pai AS, Leaf EM, Yang HY, Bartley BA, Quan KK, et al. Phosphate feeding induces arterial medial calcifcation in uremic mice: role of serum phosphorus, fbroblast growth factor-23, and osteopontin. Kidney Int. 2009;75:1297-1307.
26. Pai A, Leaf EM, El-Abbadi M, Giachelli CM. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcifcation in a uremic mouse model of chronic kidney disease. Am J Pathol. 2011;178:764-773.
27. Lau WL, Leaf EM, Hu MC, Takeno MM, Kuro-o M, Moe OW, et al. Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcifcation in mice with chronic kidney disease fed a high phosphate diet. Kidney Int. 2012;82:1261-1270.
28. Ivandic BT, Utz HF, Kaczmarek PM, Aherrahrou Z, Axtner SB, Klepsch C, et al. New Dyscalc loci for myocardial cell necrosis and calcifcation (dystrophic cardiac calcinosis) in mice. Physiol Genomics. 2001;6:137-144.
29. Festing MH, Speer MY, Yang HY, Giachelli CM. Generation of mouse conditional and null alleles of the type III sodium-dependent phosphate cotransporter PiT-1. Genesis. 2009;47:858-863.
30. Li L, Miano JM, Cserjesi P, Olson EN. SM22 alpha, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res. 1996;78:188-195.
31. Beck L, Leroy C, Salaün C, Margall-Ducos G, Desdouets C, Friedlander G. Identifcation of a novel function of PiT1 critical for cell proliferation and independent of its phosphate transport activity. J Biol Chem. 2009;284:31363-31374.
32. Byskov K, Jensen N, Kongsfelt IB, Wielsøe M, Pedersen LE, Haldrup C, et al. Regulation of cell proliferation and cell density by the inorganic phosphate transporter PiT1. Cell Div. 2012;7:7.
33. Ravera S, Virkki LV, Murer H, Forster IC. Deciphering PiT transport kinetics and substrate specifcity using electrophysiology and fux measurements. Am J Physiol, Cell Physiol. 2007;293:C606-C620.
34. Virkki LV, Biber J, Murer H, Forster IC. Phosphate transporters: a tale of two solute carrier families. Am J Physiol Renal Physiol. 2007;293: F643-F654.
35. Suzuki A, Ghayor C, Guicheux J, Magne D, Quillard S, Kakita A, et al. Enhanced expression of the inorganic phosphate transporter Pit-1 is involved in BMP-2-induced matrix mineralization in osteoblast-like cells. J Bone Miner Res. 2006;21:674-683.
36. Yoshiko Y, Candeliere GA, Maeda N, Aubin JE. Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol. 2007;27:4465-4474.
37. Sugita A, Kawai S, Hayashibara T, Amano A, Ooshima T, Michigami T, et al. Cellular ATP synthesis mediated by type III sodium-dependent phosphate transporter Pit-1 is critical to chondrogenesis. J Biol Chem. 2011;286:3094-3103.
38. Li X, Yang HY, Giachelli CM. BMP-2 promotes phosphate uptake, phe-notypic modulation, and calcifcation of human vascular smooth muscle cells. Atherosclerosis. 2008;199:271-277.
39. Villa-Bellosta R, Levi M, Sorribas V. Vascular smooth muscle cell calci-fcation and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi. Pfugers Arch. 2009;458:1151-1161.
40. Bai L, Collins JF, Xu H, Xu L, Ghishan FK. Molecular cloning of a murine type III sodium-dependent phosphate cotransporter (Pit-2) gene promoter. Biochim Biophys Acta. 2001;1522:42-45.
41. Forand A, Beck L, Leroy C, Rousseau A, Boitez V, Cohen I, et al. EKLF-driven PIT1 expression is critical for mouse erythroid maturation in vivo and in vitro. Blood. 2013;121:666-678.
42. Richardson C, Bank A. Developmental-stage-specifc expression and regulation of an amphotropic retroviral receptor in hematopoietic cells. Mol Cell Biol. 1996;16:4240-4247.
43. Chien ML, O'Neill E, Garcia JV. Phosphate depletion enhances the stability of the amphotropic murine leukemia virus receptor mRNA. Virology. 1998;240:109-117.
44. Wider C, Dickson DW, Schweitzer KJ, Broderick DF, Wszolek ZK. Familial idiopathic basal ganglia calcifcation: a challenging clinical-pathological correlation. J Neurol. 2009;256:839-842.
45. Honjo S, Yokote K, Fujimoto M, Takemoto M, Kobayashi K, Maezawa Y, et al. Clinical outcome and mechanism of soft tissue calcifcation in Werner syndrome. Rejuvenation Res. 2008;11:809-819.